Science Explorer Back to mapMap
Discussion
Researcher · EuroEspes Biomedical Research Center · Spain

Pablo Cacabelos

Pablo Cacabelos publishes mostly in Molecular Biology, Physiology and Pharmacology, on topics such as Epigenetics and DNA Methylation, Alzheimer's disease research and treatments and Cholinesterase and Neurodegenerative Diseases.

OpenAlex
World rank
#4,162,714
of 7,710,434 ranked researchers
Rank in Spain
#95,379
of 204,306
Works
27
Citations
430
Citations per work
15.9
h-index
12
i10-index 12Top 65% in Molecular Biology
Pablo Cacabelos

What does Pablo Cacabelos research?

Pablo Cacabelos's work is mostly in Biochemistry, Genetics and Molecular Biology (38%), Medicine (25%), Neuroscience (8%).

Life Sciences: 12 works · 45.8% of their workBiochemistry, Genetics and Molecular Biology: 10 works · 37.5% of their workMolecular Biology: 9 works · 31.9% of their workGenetics: 2 works · 5.6% of their workNeuroscience: 2 works · 8.3% of their workCellular and Molecular Neuroscience: 2 works · 8.3% of their workEverything else: 8 works · 29.3% of their workHealth Sciences: 7 works · 24.9% of their workMedicine: 7 works · 24.9% of their workPhysiology: 3 works · 9.7% of their workPharmacology: 2 works · 8.3% of their workNeurology: 2 works · 6.9% of their workTHEIR WORKPablo Cacabelos27works
Life Sciences46%Health Sciences25%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1037.5%
    2. Neuroscience28.3%
  2. Everything else829.3%
    1. Medicine724.9%
  1. 1Molecular Biology32% of their works
  2. 2Physiology10% of their works
  3. 3Pharmacology8% of their works
  4. 4Cellular and Molecular Neuroscience8% of their works
  5. 5Neurology7% of their works
  6. 6Genetics6% of their works

Research topics

Which keywords describe Pablo Cacabelos's research?

The keywords of their largest research topics: Neurodegeneration, DNA Methylation, Histone Modification, Amyloid Hypothesis, Pharmacokinetics, Tau Pathology, Acetylcholinesterase and Cholinesterase Inhibitors.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Neurodegeneration102 topics
  2. DNA Methylation71 topic
  3. Histone Modification71 topic
  4. Amyloid Hypothesis61 topic
  5. Pharmacokinetics62 topics
  6. Tau Pathology61 topic
  7. Acetylcholinesterase51 topic
  8. Cholinesterase Inhibitors51 topic
  9. NR4A241 topic
  10. Nurr141 topic
  11. Cytochrome P45031 topic
  12. HDAC Inhibitors31 topic
  13. Histone Deacetylases31 topic
  14. Molecular Docking31 topic
  15. Pharmacogenetics31 topic
  16. Virtual Screening31 topic
  17. Genetic Variants21 topic
  18. Sequence Interpretation21 topic

Where does Pablo Cacabelos work?

Pablo Cacabelos's main affiliation in the publication record is EuroEspes Biomedical Research Center, Spain.

How many publications and citations does Pablo Cacabelos have?

OpenAlex counts 27 works and 430 citations for Pablo Cacabelos, an h-index of 12, ranking #4,162,714 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Pablo Cacabelos. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.